A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes
- Diabetes Mellitus
- Type2 Diabetes
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 50 years and 85 years
- Gender
- Both males and females
Description
A prospective NOD Cohort of 10,000 eligible, enrolled subjects will be assembled over the next 3 years, with each patient participating for up to 3 years from the date they meet biochemical (glycemic) criteria for diabetes. Sites electronic medical record databases or other avenues for recruitment, ...
A prospective NOD Cohort of 10,000 eligible, enrolled subjects will be assembled over the next 3 years, with each patient participating for up to 3 years from the date they meet biochemical (glycemic) criteria for diabetes. Sites electronic medical record databases or other avenues for recruitment, such as physician and self referral, will be utilized to identify subjects meeting criteria for NOD.
Tracking Information
- NCT #
- NCT03731637
- Collaborators
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Alliance for Clinical Trials in Oncology
- Investigators
- Study Chair: Suresh Chari, MD M.D. Anderson Cancer Center Study Chair: Anirban Maitra, MBBS M.D. Anderson Cancer Center
Get Well Soon